Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
Insider CIK 1903360 · AVLN 10% owner · MBX 10% owner · RYZB 10% owner · CRGX 10% owner · UPB 10% owner · MTSR 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVLN Avalyn Pharma Inc. | C Conversion deriv | 2026-05-01 | 2026-05-01 | 4,060,259 | — | $0 | 0 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion deriv | 2026-05-01 | 2026-05-01 | 20,482,289 | — | $0 | 0 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion | 2026-05-01 | 2026-05-01 | 1,275,486 | — | $0 | 1,275,486 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-01-30 | 2025-02-03 | 4,365,079 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion | 2025-01-30 | 2025-02-03 | 1,857,699 | — | $0 | 1,857,699 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion deriv | 2024-10-15 | 2024-10-15 | 852,940 | — | $0 | 0 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion | 2024-10-15 | 2024-10-15 | 894,733 | — | $0 | 894,733 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 16,666,666 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 4,854,368 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 403,787 | — | $0 | 1,790,122 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 1,386,335 | — | $0 | 1,386,335 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion deriv | 2023-11-14 | 2023-11-16 | 10,000,000 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion | 2023-11-14 | 2023-11-16 | 737,000 | — | $0 | 737,000 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-19 | 1,557,846 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion | 2023-09-19 | 2023-09-19 | 1,557,846 | — | $0 | 1,557,846 | SEC↗ |